Specifically, LABA/LAMA/ICS results in remarkable inhibition of the synthesis and release of inflammatory cytokines, such as TNF-α, LTB4 and IL-6, and reducing airway inflammatory secretions in patients with COPD. This evidence concerns the gene IL6 and chronic obstructive pulmonary disease.